GlassScriptPhysician profile
Melanie Bainter
NPI 1619573771
$1,939.43
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $532 · 2023: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217 · Travel and Lodging: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.50 |
| Travel and Lodging | $191.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $565.52 | 2022-2023 | |
| Curonix LLC | $440.29 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Neurocrine Biosciences, INC. | $131.38 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $97.27 | 2022 | |
| Almatica Pharma LLC | $87.09 | 2023 | Gralise |
| Scilex Pharmaceuticals INC. | $82.32 | 2022-2023 | Ztlido |
| Lilly USA, LLC | $78.91 | 2022-2023 | Emgality, Reyvow |
| Pfizer INC. | $68.69 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.64 | 2023 | Relistor |
| Nevro Corp. | $59.47 | 2022-2023 | Senza |
| Idorsia Pharmaceuticals US INC | $47.93 | 2023 | Quviviq |
| Collegium Pharmaceutical, INC. | $45.73 | 2023 | Belbuca, Xtampza |
| Impel Pharmaceuticals INC. | $44.84 | 2022-2023 | Trudhesa |
| Saluda Medical Americas, INC. | $39.85 | 2023 | Evoke Scs |
| Amgen INC. | $23.75 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $20.83 | 2023 | Zilretta, Iovera |
| Azurity Pharmaceuticals, INC. | $19.84 | 2023 | Horizant |
| Kowa Pharmaceuticals America, INC. | $13.31 | 2022 | |
| Stimwave Technologies Incorporated | $8.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Bainter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.